A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine - Trial 2019-002603-17
Access comprehensive clinical trial information for 2019-002603-17 through Pure Global AI's free database. This phase not specified trial is sponsored by Eli Lilly and Company and is currently status unknown. The study focuses on Migraine.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to EU Clinical Trials Register data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Free Database
Powered by Pure Global AI
840K+ Trials
2019-002603-17
Trial Details
EU Clinical Trials Register • 2019-002603-17
A Study of Lasmiditan (LY573144) in Children Aged 6 to 17 With Migraine
Study Focus
Sponsor & Location
Eli Lilly and Company
Timeline & Enrollment
N/A
N/A
N/A
Primary Outcome
Pharmacokinetics (PK): Maximum Observed Drug Concentration
ICD-10 Classifications
Migraine
Other migraine
Migraine, unspecified
Complicated migraine
Headache
Data Source
EU Clinical Trials Register
2019-002603-17
Non-Device Trial